NBCNews.com | Promising Alzheimer's Drug Doesn't Help Dementia Patients NBCNews.com The drug, called solanezumab, was designed to clear the brain-clogging amyloid plaques that are one main physical symptom of Alzheimer's. But patients with early dementia due to Alzheimer's didn't seem to get much benefit from the drug, the company ... Dismay as Alzheimer's drug fails in clinical trials Results for Solanezumab in Mild Dementia of Alzheimer's Disease Announced Hopes for new Alzheimer's drug dashed |
Tag: Alzheimer’s disease
Dismay as Alzheimer’s drug fails in clinical trials – The Guardian
The Guardian | Dismay as Alzheimer's drug fails in clinical trials The Guardian In a statement, the company said: “Lilly will not pursue regulatory submissions for solanezumab for the treatment of mild dementia due to Alzheimer's disease.” Lilly's shares plunged 14% on Wednesday before markets opened. The same drug failed in a ... Promising Alzheimer's Drug Doesn't Help Dementia Patients Alzheimer's drug 'disappointment': Widely anticipated drug to treat disease fails in trial Eli Lilly's Experimental Alzheimer's Drug Failed in Large Trial |
Alzheimer’s drug ‘disappointment’: Widely anticipated drug to treat disease fails in trial – Express.co.uk
Express.co.uk | Alzheimer's drug 'disappointment': Widely anticipated drug to treat disease fails in trial Express.co.uk It failed to slow cognitive decline in people with mild Alzheimer's disease. If it had been successful, it would have been the first new treatment for dementia since 2003, and the first to slow the progression of Alzheimer's. Jeremy Hughes, chief ... Dismay as Alzheimer's drug fails in clinical trials Promising Alzheimer's Drug Doesn't Help Dementia Patients Hopes for new Alzheimer's drug dashed |
Eli Lilly Alzheimer’s Drug Fails Trial – Wall Street Journal
Wall Street Journal | Eli Lilly Alzheimer's Drug Fails Trial Wall Street Journal Alzheimer's is a progressive form of dementia that causes memory, thinking and behavioral problems with symptoms worsening as someone ages. Phase 3 clinical trials are typically the last phase before a drug seeks approval from the Food and Drug ... Hopes for new Alzheimer's drug dashed Lilly's solanezumab flunks late-stage study in Alzheimer's-related dementia; shares down 14% premarket; Biogen ... Eli Lilly Shares Plunge as Alzheimer's Trial Fails to Achieve Goals |
Families living with Alzheimer’s learn patience trumps tradition during holidays – Fox News
Fox News | Families living with Alzheimer's learn patience trumps tradition during holidays Fox News Patients with MCI experience memory problems greater than normally expected with aging but do not show other symptoms of dementia, according to the Alzheimer's Association. Patients are more likely to develop Alzheimer's disease or other dementias ... |
Awakenings: Hannah Peel on how she harnessed music’s power to cut through dementia – The Guardian
Awakenings: Hannah Peel on how she harnessed music's power to cut through dementia The Guardian Peel wanted to understand the science behind the disease, and turned to Selina Wray, a fellow Barnsley native who works at the Institute of Neurology at University College London, researching dementia for Alzheimer's Research UK. “I grow cells in the ... |
A luxury care home for people with dementia – but at what price? – The Guardian
The Guardian | A luxury care home for people with dementia – but at what price? The Guardian Chelsea Court Place describes itself as the UK's first luxury purpose-built and designed residential and daycare home for people with Alzheimer's and dementia. Inside the building on the exclusive King's Road in London, it feels more like a private ... Dementia training now available |
Alzheimer’s and Dementia Caregiver Seminar – The Pioneer News
Alzheimer's and Dementia Caregiver Seminar The Pioneer News Bring your lunch (dessert provided) and listen to speakers who will teach you about strategies and resources available to help you and your loved one. Stop in from 11 a.m. until 2 p.m. on Monday, Nov. 28, at Ridgway Memorial Library in Shepherdsville ... |
Dementia Risk Declines, And Education May Be One Reason Why – NPR
NPR | Dementia Risk Declines, And Education May Be One Reason Why NPR Some encouraging news in the battle against Alzheimer's disease and other forms of dementia: The rate at which older Americans are getting these conditions is declining. That's according to a study published Monday in JAMA Internal Medicine ... Alzheimer, dementia rates decline but aging America may halt trend Alzheimer's Society responds as researchers report decline in the prevalence of dementia in USA Dementia Rates Might Be Declining, New Study Finds |
Dementia doll abuse carers at Rochdale nursing home detained – BBC News
BBC News | Dementia doll abuse carers at Rochdale nursing home detained BBC News The 29-bedroom nursing home which cares for people with dementia and Alzheimer's disease was placed in special measures earlier this year by the Care Quality Commission. The CQC said in a statement after sentencing it was "pleased" with the outcome ... Carers who abused patients with a dementia doll have been jailed |